These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37507586)

  • 1. Abr, a Rho-regulating protein, modulates osteoclastogenesis by enhancing lamellipodia formation by interacting with poly(ADP-ribose) glycohydrolase.
    Farhana F; Sakai E; Koyanagi Y; Yamaguchi Y; Alam MI; Okamoto K; Tsukuba T
    Mol Biol Rep; 2023 Sep; 50(9):7557-7569. PubMed ID: 37507586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of poly (ADP-ribose) glycohydrolase suppresses osteoclast differentiation in RANKL-stimulated RAW264 cells.
    Sasaki Y; Nakatsuka R; Inoue A; Inouchi T; Masutani M; Nozaki T
    Biochem Biophys Res Commun; 2024 Jan; 692():149309. PubMed ID: 38048727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.
    Jeong BC; Kim JH; Kim K; Kim I; Seong S; Kim N
    Bone; 2017 Feb; 95():33-40. PubMed ID: 27829167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
    Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
    Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis.
    Leung R; Wang Y; Cuddy K; Sun C; Magalhaes J; Grynpas M; Glogauer M
    J Bone Miner Res; 2010 May; 25(5):1077-91. PubMed ID: 19929439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cadmium on Rho GTPases signal transduction during osteoclast differentiation.
    He S; Zhang K; Cao Y; Liu G; Zou H; Song R; Liu Z
    Environ Toxicol; 2022 Jul; 37(7):1608-1617. PubMed ID: 35257471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-124 regulates osteoclast differentiation.
    Lee Y; Kim HJ; Park CK; Kim YG; Lee HJ; Kim JY; Kim HH
    Bone; 2013 Oct; 56(2):383-9. PubMed ID: 23867221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
    Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
    Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gα12 regulates osteoclastogenesis by modulating NFATc1 expression.
    Song MK; Park C; Lee YD; Kim H; Kim MK; Kwon JO; Koo JH; Joo MS; Kim SG; Kim HH
    J Cell Mol Med; 2018 Feb; 22(2):849-860. PubMed ID: 29077264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.
    Chen W; Zhu G; Tang J; Zhou HD; Li YP
    J Pathol; 2018 Mar; 244(3):271-282. PubMed ID: 29083488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of culture conditions for osteoclastogenesis in RAW264.7 cells.
    Cheng Y; Liu H; Li J; Ma Y; Song C; Wang Y; Li P; Chen Y; Zhang Z
    PLoS One; 2022; 17(11):e0277871. PubMed ID: 36395187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronin1C Is a GDP-Specific Rab44 Effector That Controls Osteoclast Formation by Regulating Cell Motility in Macrophages.
    Yamaguchi Y; Kadowaki T; Aibara N; Ohyama K; Okamoto K; Sakai E; Tsukuba T
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol extract of Polyscias fruticosa leaves suppresses RANKL-mediated osteoclastogenesis in vitro and LPS-induced bone loss in vivo.
    Tran PT; Dang NH; Kim O; Van Cuong P; Dat NT; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Jun; 59():152908. PubMed ID: 30981187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity.
    Hasegawa H; Kido S; Tomomura M; Fujimoto K; Ohi M; Kiyomura M; Kanegae H; Inaba A; Sakagami H; Tomomura A
    J Biol Chem; 2010 Aug; 285(33):25448-57. PubMed ID: 20547767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-31 controls osteoclast formation and bone resorption by targeting RhoA.
    Mizoguchi F; Murakami Y; Saito T; Miyasaka N; Kohsaka H
    Arthritis Res Ther; 2013; 15(5):R102. PubMed ID: 24004633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
    Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin binding LIM 1 (abLIM1) negatively controls osteoclastogenesis by regulating cell migration and fusion.
    Narahara H; Sakai E; Yamaguchi Y; Narahara S; Iwatake M; Okamoto K; Yoshida N; Tsukuba T
    J Cell Physiol; 2018 Jan; 234(1):486-499. PubMed ID: 29904924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.